Yan Lu, Wei Min, Gong Amy G, Song Pingping, Lou Jianshu, Bi Cathy W, Xu Sherry L, Xiong Aizhen, Dong Tina T, Tsim Karl W
Shenzhen Research Institute, Hong Kong University of Science and Technology, Shenzhez, China.
Institute of Botany, Jiangsu Province and Chinese Academy of Sciences, Nanjing Botanical Garden Mem. Sun Yat-Sen, Nanjing, China.
Front Cell Dev Biol. 2017 Dec 22;5:118. doi: 10.3389/fcell.2017.00118. eCollection 2017.
Kai-Xin-San (KXS), a Chinese herbal decoction, has been applied to medical care of depression for thousands of years. It is composed of two functional paired-herbs: Ginseng Radix et Rhizoma (GR)-Polygalae Radix (PR) and Acori Tatarinowii Rhizoma (ATR)-Poria (PO). The compatibility of the paired-herbs has been frequently changed to meet the criteria of syndrome differentiation and treatment variation. Currently, a modified KXS (namely KXS) was prepared by optimizing the combinations of GR-PR and ATR-PO: the new herbal formula was shown to be very effective in animal studies. However, the cellular mechanism of KXS against depression has not been fully investigated. Here, the study on KXS-induced neuronal differentiation in cultured PC12 cells was analyzed. In PC12 cultures, single application of KXS showed no effect on the neuronal differentiation, but which showed robust effects in potentiating nerve growth factor (NGF)-induced neurite outgrowth and neurofilament expression. The potentiating effect of KXS was mediated through NGF receptor, tropomyosin receptor kinase (Trk) A: because the receptor expression and activity was markedly up-regulated in the presence of KXS, and the potentiating effect was blocked by k252a, an inhibitor of Trk A. Our current results in cell cultures fully support the therapeutic efficacy of KXS against depression.
开心散(KXS)是一种中药汤剂,数千年来一直应用于抑郁症的医疗护理。它由两组功效配对药组成:人参(GR)-远志(PR)和石菖蒲(ATR)-茯苓(PO)。为了符合辨证论治和随证加减的标准,这两组配对药的配伍经常变化。目前,通过优化GR-PR和ATR-PO的组合制备了一种改良的开心散(即KXS):新的草药配方在动物研究中显示出非常有效的效果。然而,KXS抗抑郁的细胞机制尚未得到充分研究。在此,分析了KXS诱导培养的PC12细胞神经元分化的研究。在PC12培养物中,单独应用KXS对神经元分化没有影响,但在增强神经生长因子(NGF)诱导的神经突生长和神经丝表达方面显示出强大的作用。KXS的增强作用是通过NGF受体原肌球蛋白受体激酶(Trk)A介导的:因为在存在KXS的情况下,受体表达和活性明显上调,并且这种增强作用被Trk A的抑制剂K252a阻断。我们目前在细胞培养中的结果充分支持了KXS抗抑郁的治疗效果。